Information technologyFDA's foray into big data still maturing | The Journal of the American Medical Association
Since the launch of its pilot program in 2008, the U.S. Food and Drug Administration's Sentinel Initiative now contains access to claims data on about 200 million patients and 5.5 billion patient encounters across the country.
PharmaceuticalsWhen does hyping a product become a criminal act? Theranos may be about to find out | Stat
When does hype cross the line into illegal activity? That's the big question animating criminal and civil probes into Theranos, the once high-flying Silicon Valley startup that aimed to revolutionize medical testing by developing technology that could perform an array of lab tests with just a few drops of blood.
Medical devices and equipmentSt. Jude Medical beats analysts' earnings estimates for quarter | Minneapolis Star Tribune
St. Jude Medical on Wednesday reported adjusted diluted earnings per share of 90 cents, which beat analysts' estimates by two cents for the quarter.
Safety, quality and clinical practiceNIH halts some research amid concerns over contamination and safety | NPR
The National Institutes of Health has suspended work at a pair of its facilities that manufacture products given to people who are enrolled in research studies. The organization said the facilities have not complied with safety standards meant to protect people who are already sick from inappropriate risks.
Small study supports new stool-based colon cancer test | The Philadelphia Inquirer
A new study has found more evidence that recently approved Cologuard, a stool-based colon cancer test, may be effective for certain patients.